Wildlife Health Market Size To Reach $5.4 Billion By 2033

Wildlife Health Market Growth & Trends

The global wildlife health market size is estimated to reach USD 5.4 billion by 2033, expanding at a CAGR of 9.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. The demand for zoonotic disease prevention, sustainable ecosystem management, and animal conservation are driving the market. The market landscape is being shaped by cutting-edge technology, greater investment, and the adoption of the ‘One Health’ strategy. The quadripartite Organizations - FAO (Food and Agriculture Organization, UN, WOAH (World Organization for Animal Health), WHO (World Health Organization), and UNEP (United Nations Environment Programme) - collaboratively developed ‘One Health Joint Plan of Action (2022-2026)’ to enhance the conservation of wildlife management and overall animal & human wellbeing.

The effective management of wildlife health requires cooperation amongst stakeholders, including governmental organizations, academic institutions, conservation groups, and local populations. Innovative ideas and enhanced conservation outcomes can result from the creation of platforms for information sharing and cooperation. For instance, in September 2021, a cooperative agreement was signed by Virbac and Jectas Innovators for the development of animal health vaccines. The emergence of COVID-19 has emphasized the value of researching zoonotic illnesses or infections from wild animal reservoirs. To stop future outbreaks and safeguard the well-being of humans and wildlife, it is essential to look into the origins, transmission routes, and potential hosts of zoonotic illnesses.

Although the vulnerability of many wildlife species to COVID-19 has not been thoroughly investigated, some preliminary study suggests that some animals, like minks, may be able to contract the virus. COVID-19 outbreaks in mink farms occurred in a number of nations, which necessitated the mass killing of afflicted animals to stop the virus's spread. Initiatives to promote veterinary care for wild animals in zoos, sanctuaries, and national parks, among others, have been implemented by various wildlife resources and organizations. For instance, the World Wildlife Fund (WWF) has been collaborating with partners from nearly 100 countries to sustain the healthcare of wildlife and people. The organization has over 5 million members registered globally, with over 1.3 million in the U.S. Similarly, the Association of Zoos and Aquariums (AZA) funds more than 2,500 wildlife conservation projects in over 100 countries worldwide. These measures are largely boosting the growth of the market.

 Request a free sample copy or view report summary: Wildlife Health Market Report

Wildlife Health Market Report Highlights

• On the basis of animal, the mammals segment dominated the market with the largest revenue share in 2025 due to its high disease burden, greater veterinary intervention requirements, and strong conservation focus across captive and free-ranging populations.

• The birds segment is expected to witness the fastest CAGR over the forecast period, due to rising concerns regarding avian influenza, Newcastle disease, habitat-related injuries, and migratory disease transmission.

• On the basis of sales channel, the direct sales segment held the largest market share in 2025. The segment’s growth is influenced by large-volume procurement by zoos, wildlife sanctuaries, government forest departments, national parks, and conservation agencies.

• On the basis of end use, the captive facilities segment dominated the market in 2025, driven by continuous veterinary care requirements across zoos, aquariums, rescue centers, and rehabilitation facilities where wildlife remains under direct human supervision.

• North America held more than a 30% share of the market in 2022. On the other hand, the Asia Pacific region is anticipated to grow at the fastest CAGR of approximately 11% over the projected period

Wildlife Health Market Segmentation

Grand View Research has segmented the global wildlife health market based on product, animal, end use, sales channel, and region:

Wildlife Health Animal Outlook (Revenue, USD Million, 2021 - 2033)

• Mammals

• Birds

• Aquatic Species

• Reptiles

• Amphibians

Wildlife Health Product Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceuticals

  • Anti-infectives

  • Parasiticides

  • Analgesics

  • Sedatives

  • Others

• Vaccines

• Diagnostics

  • Consumables, reagents and kits

  • Instruments and devices

• Equipment & Disposables

  • Critical Care Consumables

  • Anesthesia Equipment

  • Health Monitoring Equipment

  • Rescue & Resuscitation Equipment

  • Research Equipment

  • Others

• Others

Wildlife Health End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Captive Facilities

• Research Institutions

• Others

Wildlife Health Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Direct Sales

• Distributors/GPO Sales

Wildlife Health Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players in Wildlife Health Market

• Zoetis

• Boehringer Ingelheim International GmbH

• Tecnovax

• Jorgensen Laboratories.

• WEDGEWOOD PHARMACY

• Hallowell EMC

• NexGen Pharmaceuticals.

• Virbac

• IDEXX Laboratories

• Avian & Exotic Animal Clin Path Labs